GlassScriptPhysician profile
Priya Asija
NPI 1982817771
$3,081.08
in general payments reported to CMS, 2019-2025
42 companies · $1,211 in 2025
The $1,211 reported for 2025 was more than what 89% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $103 · 2024: $1,768 · 2025: $1,211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,070 · Education: $11.56.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,069.52 |
| Education | $11.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $401.95 | 2024-2025 | Airsupra, Farxiga, Wainua |
| Smith+Nephew, INC. | $347.52 | 2024 | Grafix Pl, Oasis, Stravix |
| Organogenesis INC. | $193.31 | 2024-2025 | Apligraf, Puraply Am, Simplimax |
| Novo Nordisk INC | $164.17 | 2024-2025 | Wegovy, Ozempic |
| E.R. Squibb & Sons, L.L.C. | $139.92 | 2023-2025 | Camzyos, Eliquis |
| Heartflow, INC. | $137.73 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $134.33 | 2024-2025 | Verquvo, Winrevair |
| Novartis Pharmaceuticals Corporation | $126.73 | 2024-2025 | |
| Mimedx Group, INC. | $120.56 | 2024-2025 | |
| Bridgebio Pharma, INC. | $104.99 | 2025 | Attruby |
| Paratek Pharmaceuticals, INC. | $95.04 | 2024-2025 | Nuzyra, Xhance |
| Alnylam Pharmaceuticals INC. | $92.00 | 2024-2025 | Onpattro |
| Vertex Pharmaceuticals Incorporated | $76.09 | 2024-2025 | |
| Solventum Corporation | $72.55 | 2024-2025 | Activ.A.C., Prevena, V.A.C. Dermatac |
| Abbott Laboratories | $68.86 | 2024-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Absolute Pro |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $62.10 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Cvrx, INC. | $60.08 | 2024 | Barostim Neo System |
| Lantheus Medical Imaging, INC. | $43.72 | 2024-2025 | |
| Pfizer INC. | $43.53 | 2024-2025 | |
| Amgen INC. | $38.49 | 2024-2025 | Otezla, Repatha, Evenity |
| Astellas Pharma US INC | $38.21 | 2025 | Veozah |
| Urgo Medical North America, LLC | $35.52 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Laborie Medical Technologies Corp. | $34.43 | 2024-2025 | Eclipse |
| Baxter Healthcare | $32.72 | 2024 | Perclot, Hillrom - Cardiac Ambulatory Monitor |
| Kiniksa Pharmaceuticals International, Plc | $31.32 | 2024 | Arcalyst |
| Axsome Therapeutics, INC. | $29.73 | 2025 | Auvelity |
| Kowa Pharmaceuticals America, INC. | $29.02 | 2024 | Zoryve |
| Irhythm Technologies, INC. | $27.31 | 2024 | Zio Monitor, Zio Xt Patch |
| Biomerieux INC | $26.00 | 2025 | Biofire Spotfire Respiratory/Sore Throat (R/St) Panel |
| Cook Medical LLC | $25.01 | 2024 | Peel-Away |
| Cardiva Medical, INC. | $23.72 | 2024 | Cardiva Vascade 6/7f Vcs |
| Scpharmaceuticals INC. | $23.52 | 2024 | |
| United Therapeutics Corporation | $23.30 | 2025 | Tyvaso |
| Sumitomo Pharma America, INC. | $22.86 | 2024 | Gemtesa |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $22.36 | 2024 | Lifevest |
| Surmodics, INC. | $22.04 | 2025 | Pounce Venous Thrombectomy System, Sublime Microcatheter, 018, 200cm, Straight, Pounce Thrombectomy System |
| Becton, Dickinson and Company | $21.40 | 2023 | Rotarexs 6 F X 135 Cm |
| Bayer Healthcare Pharmaceuticals INC. | $20.67 | 2025 | |
| Musculoskeletal Transplant Foundation INC. | $19.28 | 2024 | |
| Henry Schein, INC. | $19.22 | 2024 | |
| Tactile Systems Technology INC | $15.68 | 2025 | Flexitouch Plus, Nimbl |
| Amphastar Pharmaceuticals, INC. | $14.09 | 2024 | Baqsimi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Priya Asija listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.